Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kunnuo Cell Biology, officially known as Kunnuo (Shanghai) Cell Biology Technology Co., Ltd., is a biotechnology company headquartered in Shanghai that specializes in providing life science tools and CRO services. The company focuses on the isolation, cultivation, and distribution of high-quality human primary cells and immortalized cell lines, serving as a key supplier for pharmaceutical and academic research. Its product portfolio includes tissue-specific cells from various systems, such as oncology and immunology, as well as specialized cell culture media and reagents. Kunnuo operates from dedicated facilities in Shanghai that support GMP-compliant cell production and characterization. The firm is part of the 'Kunnuo' healthcare ecosystem associated with Kunlun Capital, focusing on advancing cell-based therapeutic development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kunnuo Cell Biology.